Wai Yeung - China Biologic Independent Director
Director
Mr. Wai Keung Yeung is Independent Director of China Biologic Products, Inc. Mr. Yeung was since 2005 a partner of Albert Yeung Associate Consulting Company, a consulting company providing MA, leadership and executive coaching services to senior managers and chief executive officers. From August 2006 to February 2011, Mr. Yeung also served as a director of BMP Sunstone Corporationrationration, a company listed on NASDAQ until the companys acquisition by Sanofi. Prior to that, Mr. Yeung had spent more than 30 years in Chinas pharmaceutical industry, holding various senior sales, marketing and general management positions with major pharmaceutical corporations in Hong Kong and mainland China, including Johnson Johnson, XianJanssen, Burroughs Wellcome, Bristol MyersSquibb and GlaxoSmithKline. since 2012.
| Age | 73 |
| Tenure | 12 years |
| Phone | (86) 10 6598 3222 |
| Web | www.chinabiologic.com |
China Biologic Management Efficiency
The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Courtney Mather | Hertz Global Holdings | 39 | |
| Penny BinghamHall | BlueScope Steel Limited | 57 | |
| Nicola Evans | Lend Lease Group | 56 | |
| Vincent Intrieri | Hertz Global Holdings | 62 | |
| Anindita Mukherjee | Hertz Global Holdings | 53 | |
| Jane Hemstritch | Lend Lease Group | 63 | |
| Bruno Marchettini | Ternium SA ADR | 71 | |
| Saiyid Naqvi | Federal Home Loan | 68 | |
| Luis Andreozzi | Ternium SA ADR | 62 | |
| Richard Hutchinson | BlueScope Steel Limited | N/A | |
| Ruben Herrera | Ternium SA ADR | 62 | |
| Linda Levinson | Hertz Global Holdings | 73 | |
| Rebecca DeeBradbury | BlueScope Steel Limited | 49 | |
| Elizabeth Proust | Lend Lease Group | N/A | |
| Jennifer Lambert | BlueScope Steel Limited | 50 | |
| Gianfelice Rocca | Ternium SA ADR | 71 | |
| Anthony Williams | Federal Home Loan | 64 | |
| Carlos Condorelli | Ternium SA ADR | 68 | |
| Philip Coffey | Lend Lease Group | 56 | |
| Lloyd Jones | BlueScope Steel Limited | 64 | |
| Grace Huebscher | Federal Home Loan | 58 | |
Management Performance
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 |
China Biologic Products Leadership Team
Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Min Fang, Director | ||
| Zhijing Liu, Corporate VP | ||
| Ming Yang, CFO | ||
| Joseph Chow, Independent Director | ||
| Gang Yang, Corporate VP and General Manager of Guizhou Taibang | ||
| Xiaosheng Shao, Independent Director | ||
| Ming Yin, Sr. Corporate VP and Corporate Secretary | ||
| Zhijun Tong, Independent Director | ||
| Yungang Lu, Independent Director | ||
| Wenfang Liu, Independent Director | ||
| Wai Yeung, Independent Director | ||
| David Li, Director | ||
| David Gao, Chairman of the Board and Presidentident, CEO | ||
| Xiaoying Gao, Executive Chairman, CEO and Pres |
China Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 9.25 | |||
| Return On Asset | 5.82 | |||
| Profit Margin | 29.04 % | |||
| Operating Margin | 37.26 % | |||
| Current Valuation | 3.56 B | |||
| Shares Outstanding | 38.79 M | |||
| Shares Owned By Insiders | 45.08 % | |||
| Shares Owned By Institutions | 51.03 % | |||
| Number Of Shares Shorted | 781.13 K | |||
| Price To Earning | 31.41 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Biologic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Biologic's short interest history, or implied volatility extrapolated from China Biologic options trading.
Pair Trading with China Biologic
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Gilead Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Gilead Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Gilead Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Gilead Sciences to buy it.
The correlation of Gilead Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Gilead Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Gilead Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Gilead Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in China Stock
If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |